CRM successfully conduct the Research Proposal Writing Workshop

THANK YOU, PARTICIPANTS!

We would like to thank all our participants for the Research Proposal Writing Workshop by Dr. Masliza Mahmod! We hope all of you had gathered as much knowledge from Dr. Masliza these past 2 days.

Our heartiest appreciation to Dr. Mazliza Mahmod for accepting our invitation to conduct the workshop here with us. We thank you!

Not to forget our guest speakers Dr. Mahmoud Danaee & Dr. Ivy Chung from University of Malaya contributing your time to be with us.

A Unique Model to Accelerate Industry-sponsored Research in Malaysia – Journal for Clinical Studies

This article originally appeared in Volume 11, Issue 1 of the Journal for Clinical Studes.

The influx of industry-sponsored research (ISR) into the Asia Pacific region is continually growing due to the rising costs and complicated processes involved in drug development. Several countries within the region such as Singapore and, more notably, South Korea, have taken the initiative to develop and further strengthen their place as preferred destinations to conduct clinical trials. One such initiative is the establishment of specific entities that focus on nurturing and expanding the existing clinical trial ecosystem within the individual countries. With over 20 years of experience in conducting late-phase trials, the Malaysian government is no exception.

In the last six years, Malaysia has been steadily building a comprehensive and supportive clinical research ecosystem within the country. This includes the creation of Clinical Research Malaysia (CRM), a non-profit company wholly owned by the Ministry of Health (MOH).1 This review will present CRM as a unique business model, established to create a thriving and comprehensive ecosystem for ISRs in Malaysia and how this business model may be relevant and replicated in Asian countries that are looking to focus on attracting ISRs. Read more

Malaysia Collaborates with Two Prominent Singapore Organisations to Advance Clinical Research (VIDEO)

L-R: Dr. Zubaidah Zakariah, Prof. Chng Wee Joo, Dr. Akhmal Yusof, Dato’ Dr. Fadzillah Kamaludin, Datuk Dr. Noor Hisham Abdullah, Datuk Seri Dr. Dzulkefly Ahmad, Mr. Choo Chee Kong, Dato’ Seri Dr. Chen Chaw Min, Dato’ Dr. Goh Pik Pin

KUALA LUMPUR, 26 February 2019 – Clinical Research Malaysia (CRM) inked two Memorandum of Understanding (MoU) with two prominent Singapore organizations in the field of clinical research. This will further pave the way for better Malaysia–Singapore collaborations in advancing drug development and research capabilities between both countries. Read more

Malaysia Pharma Report 2018

Through exclusive interviews with the Malaysian Minister of Health as well as the head of the country’s regulatory body – the NPRA – this report examines emerging trends in Malaysian healthcare, with Prime Minister Tun Dr. Mahathir Mohamad spearheading a bold health policy reform.

Also explored is the emergence of the halal medicine niche – where Malaysia has the potential to be a global leader given its geographic links to Southeast Asia and cultural ties to the Middle East – the first Malaysian biosimilars, the country’s outstanding potential as a regional clinical research hub and the rise of medical tourism.